Skip to content

Survey on changes in skin condition due to female hormones around menopause

Survey on changes in skin condition due to female hormones around menopause - Survey on changes in skin condition due to female hormones around menopause

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000060908
Enrollment
40
Registered
2026-03-16
Start date
2026-03-13
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy adults

Interventions

None listed

Sponsors

Pias Corporation
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1) Japanese females aged 45 to 55 years old at the time of informed consent 2) Those who can consent to undergoing tape stripping, applying and removing tape to the skin 20 times on the same location on the inner upper arm

Exclusion criteria

Exclusion criteria: 1) Those suspected of having, or with a history of, severe digestive, liver, kidney, cardiovascular, blood, or endocrine disorders, or malignant neoplasms 2) Those with extremely irregular eating habits 3) Those with a history of alcohol or drug dependence 4) Those who consume excessive amounts of alcohol (exceeding 20g/day) six or more days per week 5) Those with chronic inflammation (e.g., diabetes, liver disease, autoimmune disorders), kidney disease, digestive disorders, heart disease, respiratory disease, peripheral vascular disease, or other serious underlying conditions 6) Those currently undergoing treatment for any disease 7) Those currently taking medications (including over-the-counter products) or supplements with estrogenic effects 8) Those currently participating in another clinical trial, or who participated within the past month 9) Those who wish to become pregnant during the trial, are pregnant (including those who may be pregnant), or are breastfeeding 10) Those with current allergic skin conditions such as atopic dermatitis 11) Those who have experienced allergic reactions to food or cosmetics 12) Those who have undergone cosmetic medical procedures or special skincare treatments (e.g., peeling, hair removal) within 4 weeks prior to the trial start date, or plan to undergo such procedures during the trial period 13) Those who have been exposed to ultraviolet rays beyond normal daily activities (e.g., prolonged outdoor work, exercise, swimming, leisure activities) within 4 weeks prior to the trial start date, or who plan to do so during the trial period 14) Those with irregular daily rhythms, such as night shift workers or those on rotating day-night shifts 15) Those who smoke an average of 21 or more cigarettes per day 16) Those who engage in strenuous sports or are currently dieting

Design outcomes

Primary

MeasureTime frame
1. blood test (Hematological tests, estradiol, follicle-stimulating hormone(FSH), progesterone, anti-Mullerian hormone(AMH),IL-6,CRP,TNF-alpha,total antioxidant capacity(PAO), pentosidine) 2. skin pH 6. analysis of horny cell layer 7. questionnaire

Countries

Japan

Contacts

Public ContactMiwa Kaneko

SOUKEN Co., Ltd Management Division

jimukyoku@mail.souken-r.com0354081555

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026